Whitney Evans, PhD, RD, Director of Scientific Affairs at Danone, said: GLP-1 medications can lead to substantial weight loss, but they can also create unique nutrition challenges as they can substantially reduce food and calorie intake but do not change essential nutrient needs
Heres a chart our team at CASPR created for the obesity results from this study: Patients treated with semaglutide (Ozempic / Wegovy) showed a large reduction in the likelihood of new or recurrent cannabis use disorder (CUD) diagnoses compared to patients treated with non GLP-1 anti-obesity or anti-diabetes medications
Boost metabolism and energy levels
This level of dosing flexibility is impossible with fixed-dose pens
Talk to your doctor or pharmacist for medical advice or to discuss medication interactions with any supplement
At your maintenance dose, weight loss accelerates